Why is TTK Healthcare falling/rising?

As of 13-Aug, TTK Healthcare Ltd. is experiencing a decline in its stock price, currently at 1,140.60, which reflects a decrease of 3.7 points or 0.32%. The stock has underperformed its sector by 1.81% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, TTK Healthcare has shown a modest gain of 1.96%, but it has significantly underperformed over the longer term, with a 13.83% decline in the last month and a 27.67% drop over the past year. The company's financial performance has also been concerning, with a notable decrease in profit before tax and profit after tax in the latest quarter, alongside a low level of domestic mutual fund investment, indicating a lack of confidence among institutional investors.
In the broader market context, TTK Healthcare's recent performance contrasts with the Sensex, which has remained relatively stable with a slight decline of 0.01% over the past week. While the stock has shown some resilience in the short term, its long-term returns are troubling, with a 19.49% decline year-to-date compared to a 3.07% increase in the benchmark index. The company's low debt-to-equity ratio and attractive valuation metrics, such as a price-to-book value of 1.5, suggest potential for recovery; however, the overall negative sentiment stemming from flat quarterly results and underperformance relative to peers continues to weigh heavily on investor confidence.